Aethlon Medical (AEMD) Misses Q1 EPS by 3c

Aethlon Medical (NASDAQ: AEMD) reported Q1 EPS of ($0.16), $0.03 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $132 thousand versus the consensus estimate of $200 thousand.

For earnings history and earnings-related data on Aethlon Medical (AEMD) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• JPMorgan Upgrades Graphic Packaging Holding Company (GPK) to Overweight
• Union Pacific (UNP) Reiterated at Market Outperform by Citizens - Most Attractive in Rail Group